@article{4ada76f9a1364b1f9109f016971f2963,
title = "Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: A nationwide study from Iceland",
keywords = "Antirheumatic Agents/therapeutic use, COVID-19, COVID-19/complications, Hospitalization/statistics \& numerical data, Humans, Hypoxia/virology, Iceland/epidemiology, Methotrexate/therapeutic use, Prevalence, Rheumatic Diseases/drug therapy, SARS-CoV-2, biological therapy, epidemiology, methotrexate, tumor necrosis factors",
author = "Bj{\"o}rnsson, \{Aron Hjalti\} and Gr{\"o}ndal, \{Ger{\dh}ur Mar{\'i}a\} and M{\'a}r Kristj{\'a}nsson and {\TH}{\'o}runn J{\'o}nsd{\'o}ttir and L{\"o}ve, \{{\TH}orvar{\dh}ur J{\'o}n\} and Bj{\"o}rn Gu{\dh}bj{\"o}rnsson",
year = "2021",
month = jan,
day = "5",
doi = "10.1136/annrheumdis-2020-219564",
language = "English",
volume = "80",
pages = "671--672",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "Elsevier B.V.",
number = "5",
}